SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Gufic Biosciences

BSE: 509079|NSE: GUFICBIO|ISIN: INE742B01025|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 02, 16:01
45.50
-1.3 (-2.78%)
VOLUME 22,459
LIVE
NSE
Dec 02, 15:44
45.60
-1.4 (-2.98%)
VOLUME 46,176
Announcements on Gufic Bio

28th-Nov-2016 13:51Source: BSE

Gufic Bio- Updates on Outcome of Board Meeting - Resignation of Director

Gufic Biosciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 14, 2016, inter alia, has accepted the resignation of Mr. Ashok M. Tarale as an Indepe...

25th-Nov-2016 18:05Source: BSE

Gufic Bio- Outcome of Board Meeting

Gufic Biosciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 24, 2016, inter alia, has approved the Scheme of Amalgamation of M/s. Gufic Stridden B...

25th-Nov-2016 18:04Source: BSE

Gufic Bio- Appointment of Additional Independent Director

Gufic Biosciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 24, 2016, inter alia, has appointed Mr. Gopal Daptari as an Additional Independent Dir...

25th-Nov-2016 08:41Source: NSE

Gufic Biosciences Limited

Gufic Biosciences Limited has informed the Exchange regarding Approval of Amalgamation of M/s. Gufic Stridden Bio-Pharma Private Limited with the Company subject to necessary approvals.

15th-Nov-2016 10:56Source: NSE

Gufic Biosciences Limited

Gufic Biosciences Limited has informed the Exchange regarding Outcome of Board Meeting held on November 14, 2016.

15th-Nov-2016 09:31Source: BSE

Gufic Bio- Standalone Financial Results, Limited Review Report for September 30, 2016

Gufic Biosciences Ltd has informed BSE about :

1. Standalone Financial Results for the period ended September 30, 2016

2. Standalone Limited Review for the period ended September 30, 20...

3rd-Nov-2016 17:58Source: BSE

Gufic Bio- Board Meeting Intimation for Results & Closure of Trading Window

Gufic Biosciences Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on November 14, 2016, inter alia, to consider and approve the Unaudited Financial...

21st-Oct-2016 11:55Source: BSE

Gufic Bio- Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016

Gufic Biosciences Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (L...

18th-Oct-2016 12:10Source: BSE

Gufic Bio- Shareholding for the Period Ended September 30, 2016

Gufic Biosciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly

30th-Sep-2016 17:54Source: BSE

Gufic Bio- Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

Gufic Biosciences Ltd has informed BSE regarding the details of Voting results at the 32nd Annual General Meeting (AGM) of the Company held on September 28, 2016, under Regulation 44(3) of SEBI (LODR)...

1 2 3 4 5 Next >>
Quick Links for Gufic Biosciences
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.